Lyra Therapeutics (LYRA) Leases (2021 - 2025)
Historic Leases for Lyra Therapeutics (LYRA) over the last 5 years, with Q3 2025 value amounting to $17.6 million.
- Lyra Therapeutics' Leases fell 1512.53% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.6 million, marking a year-over-year decrease of 1512.53%. This contributed to the annual value of $19.9 million for FY2024, which is 4004.75% down from last year.
- Lyra Therapeutics' Leases amounted to $17.6 million in Q3 2025, which was down 1512.53% from $18.4 million recorded in Q2 2025.
- In the past 5 years, Lyra Therapeutics' Leases registered a high of $45.6 million during Q1 2024, and its lowest value of $608000.0 during Q3 2022.
- In the last 5 years, Lyra Therapeutics' Leases had a median value of $2.2 million in 2022 and averaged $11.4 million.
- Per our database at Business Quant, Lyra Therapeutics' Leases crashed by 6190.48% in 2022 and then skyrocketed by 240005.48% in 2024.
- Quarter analysis of 5 years shows Lyra Therapeutics' Leases stood at $1.4 million in 2021, then soared by 64.06% to $2.2 million in 2022, then skyrocketed by 1394.96% to $33.2 million in 2023, then tumbled by 40.05% to $19.9 million in 2024, then dropped by 11.79% to $17.6 million in 2025.
- Its Leases was $17.6 million in Q3 2025, compared to $18.4 million in Q2 2025 and $19.1 million in Q1 2025.